Zota Health Care (ZOTA)₹1,274+2.70%Pharmaceuticals
Zota Health Care is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of −8.0% against a peer median of 14.5%, and latest-quarter sales growth of 54.2% against a peer median of 18.9%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Orchid Pharma | 5,291 | 421.0 | 2.0 | 1.3 | 0.28 | 0.0 | 1,229 | 10 | 15.5 | — | vs ZOTA |
| Supriya Lifescience | 5,082 | 24.3 | 25.1 | 19.1 | 0.00 | 0.2 | 826 | 209 | 50.7 | 48.1 | vs ZOTA |
| SMS Pharmaceuticals | 4,809 | 46.8 | 13.0 | 14.2 | 0.46 | 0.1 | 886 | 102 | 5.6 | 4.9 | vs ZOTA |
| Gufic Biosciences | 4,760 | 64.8 | 12.0 | 10.2 | 0.61 | 0.0 | 948 | 64 | 16.6 | 69.1 | vs ZOTA |
| Aarti Drugs | 4,563 | 24.0 | 12.1 | 13.4 | 0.37 | 0.4 | 2,564 | 194 | 18.9 | −7.5 | vs ZOTA |
| Zota Health Care | 4,410 | — | −8.0 | −15.1 | 0.39 | 0.1 | 539 | −74 | 54.2 | — | — |
| Evonile Pharma | 4,343 | 44.5 | 16.0 | 11.7 | 0.00 | 0.0 | 353 | 93 | 18.1 | 14.3 | vs ZOTA |
| RPG Life Sciences | 4,283 | 39.1 | 26.0 | 19.3 | 0.03 | 0.9 | 708 | 115 | 16.4 | −24.3 | vs ZOTA |
| Gujarat Themis Biosyn | 4,138 | 88.5 | — | — | — | 0.2 | 165 | 47 | 22.3 | 22.5 | vs ZOTA |
| Kwality Pharmaceuticals | 4,011 | 49.3 | 24.0 | 22.9 | 0.39 | 0.0 | 503 | 67 | 46.0 | 116.4 | vs ZOTA |
| Shukra Pharmaceuticals | 3,618 | 110.9 | 36.9 | 28.9 | 0.06 | 0.0 | 57 | 22 | 379.2 | 1,191.1 | vs ZOTA |
| Peer median | 4,410 | 48.1 | 14.5 | 13.8 | 0.33 | 0.1 | 708 | 67 | 18.9 | 22.5 |
Listed companies closest to Zota Health Care in Pharmaceuticals include Orchid Pharma, Supriya Lifescience, SMS Pharmaceuticals, Gufic Biosciences, Aarti Drugs, Evonile Pharma, RPG Life Sciences, Gujarat Themis Biosyn.
Orchid Pharma, with a market cap of ₹5,291 Cr.
Zota Health Care's return on capital employed is −8.0%, below the peer median of 14.5%.